0001144204-11-019353.txt : 20110331
0001144204-11-019353.hdr.sgml : 20110331
20110331211711
ACCESSION NUMBER: 0001144204-11-019353
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110325
FILED AS OF DATE: 20110331
DATE AS OF CHANGE: 20110331
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brusegard David
CENTRAL INDEX KEY: 0001516920
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-25169
FILM NUMBER: 11728484
MAIL ADDRESS:
STREET 1: 33 HARBOUR SQUARE
CITY: TORONTO
STATE: A6
ZIP: M5J 2G2
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GENEREX BIOTECHNOLOGY CORP
CENTRAL INDEX KEY: 0001059784
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 820490211
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0731
BUSINESS ADDRESS:
STREET 1: 33 HARBOUR SQ
STREET 2: STE 202
CITY: TORONTO ONTARIO CANADA
STATE: A1
ZIP: M5J 2G2
BUSINESS PHONE: 4163642551
MAIL ADDRESS:
STREET 1: 33 HARBOUR SQ
STREET 2: STE 202
CITY: TORONTO ONTARIO CA
STATE: A1
ZIP: M5J 2G2
3
1
v217161_ex.xml
X0203
3
2011-03-25
0
0001059784
GENEREX BIOTECHNOLOGY CORP
GNBT
0001516920
Brusegard David
C/O GENEREX BIOTECHNOLOGY CORPORATION
33 HARBOUR SQUARE, SUITE 202
TORONTO
A6
M5J 2G2
ONTARIO, CANADA
0
1
0
0
Chief Operating Officer
Common Stock
31295
D
Common Stock Option (right to buy)
0.282
2011-03-25
2016-03-25
Common Stock
200000
D
/s/ David A. Brusegard
2011-03-31